LATS1 and chronic myelogenous leukemia, BCR-ABL1 positive: To further determine the biological effects of LATS1/2 on other aspects of CML cell property, TRULI-treated K562 cells were subjected to clonogenicity, migration, and reactive oxygen species (ROS) detection assays.